Publications - selection



  • Mouhou E, Genty F, El M’selmi W, Chouali H, Zagury JF, Le Clerc S, Proudhon C, Noirel J. (2023). High tissue-specificity of lncRNAs maximises the prediction of tissue of origin of circulating DNA [Preprint]. bioRxiv . 10.1101/2023.01.19.524838


  • Tkach M, Hego C, Michel M, Darrigues L, Pierga JY, Bidard FC, Théry C, Proudhon C. (2022). Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer. Journal of Extracellular Biology, 1(7). 10.1002/jex2.51


  • Silveira AB, Bidard FC, Tanguy ML, Girard E, Trédan O, Dubot C, Jacot W, Goncalves A, Debled M, Levy C, Ferrero JM, Jouannaud C, Rios M, Mouret-Reynier MA, Dalenc F, Hego C, Rampanou A, Albaud B, Baulande S, Berger F, Lemonnier J, Desmoulins I, Renault S, Proudhon C, Pierga JY*. (2021). Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. Npj Breast Cancer, 7(1), 115. 10.1038/s41523-021-00319-4
  • Darrigues L, Pierga JY, Bernard-Tessier A, Bièche I, Silveira AB, Michel M, Loirat D, Cottu P, Cabel L, Dubot C, Geiss R, Ricci F, Vincent-Salomon A, Proudhon C and Bidard FC. (2021). Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients. Breast Cancer Research, 23(1), 31. 10.1186/s13058-021-01411-0


  • Silveira AB, Bidard FC, Kasperek A, Melaabi S, Tanguy ML, Bataillon G, Cabel L, Buecher B, Pierga JY, Proudhon C, Stern MH. (2020). High-accuracy determination of microsatellite instability compatible with liquid biopsies. Clinical Chemistry, 66(4), 606‑613. 10.1093/clinchem/hvaa013
  • Jeannot E, Darrigues L, Michel M, Stern MH, Pierga JY, Rampanou A, Melaabi S, Benoist C, Bieche I, Vincent-Salomon A, El Ayachy R, Noret A, Epaillard N, Cabel L, Bidard FC, Proudhon C. (2020). A single droplet digital PCR for ESR1 activating mutations detection in plasma. Oncogene, 39(14), 2987‑2995. 10.1038/s41388-020-1174-y


  • Decraene, C., Bortolini Silveira, A., Michel, M., Bidard, F.-C., Pierga, J.-Y., Stern, M.-H., Proudhon C. (2018). Single droplet digital polymerase chain reaction for comprehensive and simultaneous detection of mutations in hotspot regions. Journal of Visualized Experiments, (139), 58051. 10.3791/58051
  • Decraene C, Silveira AB, Bidard FC, Vallée A, Michel M, Melaabi S, Vincent-Salomon A, Saliou A, Houy A, Milder M, Lantz O, Ychou M, Denis MG, Pierga JY, Stern MH, Proudhon C. (2018). Multiple hotspot mutations scanning by single droplet digital pcr. Clinical Chemistry, 64(2), 317‑328. 10.1373/clinchem.2017.272518


  • Cabel L, Riva F, Servois V, Livartowski A, Daniel C, Rampanou A, Lantz O, Romano E, Milder M, Buecher B, Piperno-Neumann S, Bernard V, Baulande S, Bieche I, Pierga JY, Proudhon C, Bidard FC. (2017). Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy : A proof-of-concept study. Annals of Oncology, 28(8), 1996‑2001. 10.1093/annonc/mdx212
  • Riva F, Bidard FC, Houy A, Saliou A, Madic J, Rampanou A, Hego C, Milder M, Cottu P, Sablin MP, Vincent-Salomon A, Lantz O, Stern MH, Proudhon C, Pierga JY. (2017). Patient-specific circulating tumor dna detection during neoadjuvant chemotherapy in triple-negative breast cancer. Clinical Chemistry, 63(3), 691‑699. 10.1373/clinchem.2016.262337


  • Bidard FC, Proudhon C, Pierga JY.  (2016). Circulating tumor cells in breast cancer. Molecular Oncology, 10(3), 418‑430. 10.1016/j.molonc.2016.01.001
  • Saliou A, Bidard FC, Lantz O, Stern MH, Vincent-Salomon A, Proudhon C, Pierga JY. (2016). Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions. Expert Review of Molecular Diagnostics, 16(1), 39‑50. 10.1586/14737159.2016.1121100